Show simple item record

dc.contributor.authorZenner, D
dc.contributor.authorMolinar, D
dc.contributor.authorNichols, T
dc.contributor.authorRiha, J
dc.contributor.authorMacintosh, M
dc.contributor.authorNardone, A
dc.identifier.citationZenner, D., Molinar, D., Nichols, T. et al. Should young people be paid for getting tested? A national comparative study to evaluate patient financial incentives for chlamydia screening. BMC Public Health 12, 261 (2012).
dc.description.abstractBACKGROUND: Patient financial incentives ("incentives") have been widely used to promote chlamydia screening uptake amongst 15-24 year olds in England, but there is scarce evidence of their effectiveness. The objectives of the study were to describe incentives used to promote chlamydia screening in Primary Care Trusts (PCTs) in England and to evaluate their impact on coverage and positivity rate. METHODS: PCTs that had used incentives between 1/1/2007 and 30/6/2009 (exposed) were matched by socio-demographic profile and initial screening coverage with PCTs that had not (unexposed). For each PCT, percentage point change in chlamydia screening coverage and positivity for the period before and during the incentive was calculated. Differences in average change of coverage and positivity rate between exposed and unexposed PCTs were compared using linear regression to adjust for matching and potential confounders. RESULTS: Incentives had a significant effect in increasing average coverage in exposed PCTs (0.43%, CI 0.04%-0.82%). The effect for voucher schemes (2.35%) was larger than for prize draws (0.16%). The difference was greater in females (0.73%) than males (0.14%). The effect on positivity rates was not significant (0.07%, CI -1.53% to 1.67%). CONCLUSIONS: Vouchers, but not prize draws, led to a small absolute but large relative increase in chlamydia screening coverage. Incentives increased coverage more in females than males but had no impact on reported positivity rates. These findings support recommendations not to use prize draws to promote chlamydia screening and contribute to the evidence base of the operational effectiveness of using patient incentives in encouraging public health action.en_US
dc.format.extent261 - ?
dc.relation.ispartofBMC Public Health
dc.rightsCreative Commons Attribution License
dc.subjectAwards and Prizesen_US
dc.subjectChlamydia Infectionsen_US
dc.subjectHealth Behavioren_US
dc.subjectHealth Promotionen_US
dc.subjectMass Screeningen_US
dc.subjectNational Health Programsen_US
dc.subjectPatient Acceptance of Health Careen_US
dc.subjectReimbursement, Incentiveen_US
dc.subjectSex Distributionen_US
dc.subjectSocioeconomic Factorsen_US
dc.subjectYoung Adulten_US
dc.titleShould young people be paid for getting tested? A national comparative study to evaluate patient financial incentives for chlamydia screening.en_US
dc.rights.holder© 2012 Zenner et al; licensee BioMed Central Ltd
pubs.notesNot knownen_US
pubs.publication-statusPublished onlineen_US
rioxxterms.funderDefault funderen_US
rioxxterms.identifier.projectDefault projecten_US

Files in this item


This item appears in the following Collection(s)

Show simple item record

Creative Commons Attribution License
Except where otherwise noted, this item's license is described as Creative Commons Attribution License